Compare CBD Global Sciences (CBDNF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

CBD Global Sciences (CBDNF)

Price

$0.04

Change

+16.39%

Market Cap

$1.8M

Sector

CBD

CBD Sector Peers

All CBD cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
CWBHFCharlotte's Web Holdings$0.62-0.22%$99.3M
PKANFSimply Better Brands$0.210.00%$22.2M
YCBDcbdMD Inc$0.71-0.75%$7.5M
PCLOFPharmaCielo$0.04-26.40%$7.4M
OILFFNextleaf Solutions$0.04+1.93%$7.1M
CVSICV Sciences$0.04-12.42%$6.5M
DHBUFDelivra Health Brands$0.14+10.51%$4.4M
ELLXFElixinol Global$0.010.00%$1.9M
GBHPFGlobal Hemp Group$0.010.00%$178.0K
CNTRFCentr Brands$0.010.00%$139.2K

Top Matchups by Market Cap

Companies closest to CBD Global Sciences in market capitalization — the most meaningful head-to-head comparisons.

AKANInternational

Akanda Corp

MCap: $1.7M

$0.82-2.84%
Compare
ELLXFCBD

Elixinol Global

MCap: $1.9M

$0.010.00%
Compare
AYRWFMSO

Ayr Wellness

MCap: $1.9M

$0.02-8.57%
Compare
XXIIBiotech

22nd Century Group

MCap: $2.0M

$3.88+1.97%
Compare
CANBMSO

Canbiola Inc

MCap: $1.4M

$0.020.00%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the CBD sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $10.99B

$178.55-1.66%
Compare
SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare

Comparing CBDNF in the Cannabis Market

CBD Global Sciences (CBDNF) is a CBD-sector cannabis company trading at $0.04 per share with a market capitalization of $1.8M. Among its CBD peers, CBDNF ranks #9 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved +16.39% in the current session, trading on the OTC exchange.

When comparing CBDNF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate CBD Global Sciences relative to 10 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does CBDNF compare to other CBD stocks?+
CBD Global Sciences has a market cap of $1.8M, placing it among 11 companies in the CBD sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every CBD peer.
What is CBDNF's biggest competitor?+
By market capitalization, the closest comparable company is Akanda Corp (AKAN) with a market cap of $1.7M. Click the compare link to view a full head-to-head analysis.
Is CBDNF overvalued compared to its peers?+
CBD Global Sciences trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than CBDNF?+
CBD Global Sciences has a gross margin of 0.0%. Among its CBD peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare CBDNF to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside CBD. You can click any company to see a full side-by-side comparison with CBDNF covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.